Cholesterol Lowering and CV Risk: Meta-analyses

Slide lecture program (10 slides): View & Download

1. On-Treatment LDL and CHD Events in Statin Trials
2. Second Cycle of the CTT Meta-analysis: Proportional Effects on Major VascularEvents
3. Second Cycle of the CTT Meta-analysis:More vs Less Statin
4. Second Cycle of the CTT Meta-analysis: Statin vs Control
5. Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
6. Meta-analysis of Statin Trials and Stroke Mortality
7. Stroke Risk and LDL Lowering inStatin Trials
8. Second Cycle of the CTT Meta-analysis: Proportional Effects on Cause-Specific Mortality
9. Meta-analysis of Statin Trials: Effect of Intensive LDL-C Lowering vs Standard Statin Therapy on Fatal and Nonfatal Stroke

Click on slides to preview

Download slides below

Cholesterol Lowering and CV Risk: Meta-analyses	On-Treatment LDL and CHD Events in Statin Trials
Second Cycle of the CTT Meta-analysis	Second Cycle of the CTT Meta-analysis:More vs Less Statin
Second Cycle of the CTT Meta-analysis: Statin vs Control	Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
Meta-analysis of Statin Trials and Stroke Mortality	Stroke Risk and LDL Lowering inStatin Trials
Second Cycle of the CTT Meta-analysis	Meta-analysis of Statin Trials: Effect ofIntensive LDL-C

634918750545298750-Download slides CV risk and lipid management. section 2 (PPTX 389KB)